Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Knight Therapeutics Inc
KHTRF
Primary Symbol:
T.GUD
Healthcare
Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select...
international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:GUD)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on May 29, 2023 8:15am
RE:Facts or desperation
Hahaha - makes a whole lot of sense. No one is proping up the share price - they don't care about that. ChiChi - could you kindly provide the actual purchase price in the two components in which
...more
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Post by
Chianchin
on May 29, 2023 6:36am
Facts or desperation
The whole bunch of insiders have tried everything legaly possible to prop up the share price. None of them have worked. Why? Becasue GUD with nealy a bllion dollar in cash 8 years later has not
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on May 28, 2023 3:57pm
RE:More GUD stock buys by Samira
Yes ... that actually was a huge purchase ! Understanding Samira's past role in finance and her very careful approach to share acquisition, this is a very big move for the newly minted CEO. ----
...more
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Post by
GoldenInvestor
on May 27, 2023 6:16pm
More GUD stock buys by Samira
Samira Sakhia Bought 12% More Shares In Knight Therapeutics \ Simply Wall St Fri, May 26, 2023 at 6:19 AM EDT ·3 min read In this article:
...more
(14)
•••
Lookingforclues
X
View Profile
View Bullboard History
Post by
Lookingforclues
on May 18, 2023 9:56pm
Buy backs continue!
Still buying back to keep the price up....but it is falling....gradually. Kinda UNBELIEVABLE! And Goodman Associate still 'priming'!
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Post by
Chianchin
on May 18, 2023 11:30am
Re bulls
I think losing money "gold" rustyinvestor means "Fools"
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Post by
GoldenInvestor
on May 16, 2023 3:24pm
Analysts and research firms
Can be valuable tools. it is also important to assess research and validate your own insights. There are always a wide array of terrific bulls on a given company to those that are cautious or
...more
(1914)
•••
Possibleidiot01
X
View Profile
View Bullboard History
Post by
Possibleidiot01
on May 15, 2023 8:26pm
Paradigm - cantechletter.com
By Jayson MacLean Published on May 15, 2023 Last Updated on May 15, 2023 Filed under: All posts, Analysts, Pharma and Biotech Stock: gud Knight Therapeutics
...more
(13)
•••
gudisgood
X
View Profile
View Bullboard History
Comment by
gudisgood
on May 15, 2023 5:30am
RE:Simple Takeaway - Distribution Scale
Random notes about the margins and the pipeline... In the Q4/21 earnings call Samira said they're happy with the mid-teen EBITDA margins "for now" which to me implies the expectation is
...more
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Post by
Chianchin
on May 14, 2023 3:18pm
A loss is a loss regardless the right or left pockets
This is typical accounting bambozling that investors have had to sustain for ten years. Alas ...the market does not buy the narrative any longer but empty pockets Mugsy does. If Gud ever earns fair
...more
(152)
•••
longrun86
X
View Profile
View Bullboard History
Post by
longrun86
on May 14, 2023 11:24am
Simple Takeaway - Distribution Scale
Hi folks, Lots of moving parts in this business; however, my key takeaway is that the distribution network and supporting infrastructure is in place; however, Knight needs to push more volume
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on May 13, 2023 11:31am
RE:Still losing money
Hey ChiChi. I'm having a little trouble with accounting and I was wondering if you could help. What's the difference between an accounting recorded loss and an actual financial loss? Also
...more
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Post by
Chianchin
on May 11, 2023 2:33pm
Still losing money
One billion dollar in cash 10 years later says it all. The marked popoded
(13)
•••
gudisgood
X
View Profile
View Bullboard History
Comment by
gudisgood
on May 11, 2023 7:41am
RE:2023 Guidance Updated: +$20M
VERY strong cash flows without working capital adjustments ($18.6M). With working capital adjustments: $3.7M This year $16M spent on buybacks so far.
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >